Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Incheon
Clinical trial register · South Korea

Clinical Trials in Incheon, 2026

Every study on the ClinicalTrials.gov registry that lists a site in South Korea and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 3365 matching records held by the registry are in this view. Synced 11 Oct 2026, 03:17 UTC
3365
Studies in scope
all four open statuses
1831
Recruiting now
open to new participants
500
Lead sponsors
across recruiting studies
Top sites
Seoul 195 Goyang-si 72 Daegu 59 Seongnam-si 59 Busan 50
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
AstraZeneca36 Eli Lilly and Company15 Hoffmann-La Roche14 Novartis Pharmaceuticals13 Janssen Research & Development, LLC11 Clear sponsor filter
Site location
Seoul195 Goyang-si72 Daegu59 Seongnam-si59 Busan50
All 52 locations
Target enrolment
to

Trials with a site in Incheon

36 of 3365 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in South Korea
Start
Recruiting
A Study to Investigate CV Outcomes With Elecoglipron Compared With Placebo in Adult Participants With HFpEF or HFmrEF
NCT07761117Heart Failure With Preserved Ejection Fraction (HFpEF), Heart Failure With Mildly Reduced Ejection Fraction (HFmrEF)
DrugElecoglipron
AstraZeneca
Phase 3
6,950
Busan, Daegu, Daejeon, Gwangju, Gyeonggi-do, Incheon, Seongbuk-Gu, Seoul
2026-08-24
Recruiting
AstraZeneca
Phase 3
1,500
Busan, Daegu, Daejeon, Incheon, Seoul, Suwon
2026-08-20
Recruiting
Roll-over Study for Participants Who Have Completed a Previous Clinical Study With Benralizumab (Fasenra) and Benefit From Continued Treatment
NCT07444567Asthma, Eosinophilic Granulomatosis With Polyangiitis (EGPA), Hypereosinophilic Syndrome (HES)
DrugsFasenra·Benralizumab
AstraZeneca
Phase 3
230
Incheon
2026-07-24
Recruiting
AstraZeneca
Phase 3
1,200
Busan, Changwon-si, Daegu, Daejeon, Guri-si, Incheon, Seoul
2026-07-06
Recruiting
AstraZeneca
Phase 3
4,500
Busan, Daegu, Goyang-si, Gyeonggi-do, Incheon, Jongno-gu, Seoul, Suwon
2026-06-29
Recruiting
AstraZeneca
Phase 3
150
Cheonan-si, Daegu, Goyang-si, Hwasun-eup, Incheon, Seongbuk-Gu, Seongnam-si, Seoul
2026-06-15
Recruiting
AstraZeneca
Phase 3
400
Goyang-si, Incheon, Seoul, Suwon
2025-10-31
Recruiting
AstraZeneca
Observational
130
Busan, Daejeon, Goyang-si, Guri-si, Incheon, Seongnam-si, Seoul, Suwon
2025-10-15
Recruiting
AstraZeneca
Phase 3
1,160
Changwon-si, Cheongju-si, Incheon, JinJoo, Seoul, Suwon
2024-11-18
Recruiting
Study of Volrustomig as Monotherapy or in Combination With Anti- Cancer Agents in Participants With Advanced/Metastatic Solid Tumors
NCT06535607Sub-study 1 Cervical Cancer (Volrustomig Monotherapy), Sub-study 2 Head and Neck Squamous Cell Carcinoma (Volrustomig Monotherapy), Sub-study 3 Head and Neck Squamous Cell Carcinoma (Volrustomig in Combination With Chemotherapy), Sub-study 4 Esophageal Squamous Cell Carcinoma (Volrustomig in Combination With Chemotherapy)
DrugsVolrustomig·Adrucil·Paclitaxel·Cisplatin
AstraZeneca
Phase 2
257
Incheon, Namdong-gu, Seoul
2024-08-22
Recruiting
AstraZeneca
Phase 2
80
Busan, Daegu, Gyeongsangnam-do, Incheon, Jeonju, Seogu, Seoul, Suwon
2024-07-16
Recruiting
Real-World Treatment Study of Koselugo (Selumetinib)
NCT06360406Neurofibromatosis 1, Neurofibroma, Plexiform
AstraZeneca
Observational
200
Busan, Chungcheongbuk-do, Daejeon, Gyeonggi-do, Incheon, Jeonnam, Seoul, Wŏnju
2024-06-15
Recruiting
AstraZeneca
Phase 3
675
Changwon, Incheon, Seongnam-si, Seoul, Suwon
2024-04-11
Recruiting
AstraZeneca
Phase 3
1,145
Goyang-si, Gyeonggi-do, Incheon, Seoul, Suwon
2023-12-14
Active, closed
AstraZeneca
Phase 3
895
Cheongju-si, Incheon, Jinju, Seoul, Suwon
2023-10-24
Active, closed
AstraZeneca
Phase 2
188
Busan, Cheongju-si, Daejeon, Goyang-si, Gyeonggi-do, Incheon, Seongnam-si, Seoul
2023-03-06
Active, closed
AstraZeneca
Phase 3
791
Daegu, Goyang-si, Incheon, Jinju, Seoul, Suwon
2022-02-18
Active, closed
AstraZeneca
Phase 3
148
Daejeon, Goyang-si, Incheon, Seoul
2021-10-28
Active, closed
AstraZeneca
Phase 3
712
Busan, Goyang-si, Incheon, Seongnam-si, Seoul
2021-08-05
Active, closed
AstraZeneca
Phase 3
358
Daegu, Hwasun-gun, Incheon, Seoul, Yangsan
2020-12-16
Active, closed
AstraZeneca
Phase 3
866
Daegu, Goyang-si, Incheon, Seongnam-si, Seoul
2020-07-24
Active, closed
AstraZeneca
Phase 2
240
Goyang-si, Incheon
2020-04-22
Active, closed
AstraZeneca
Phase 3
818
Busan, Daegu, Goyang-si, Incheon, Seongnam-si, Seoul, Suwon
2020-04-16
Active, closed
AstraZeneca
Phase 3
923
Busan, Cheonan-si, Cheongju-si, Daegu, Goyang-si, Incheon, Seongnam-si, Seoul
2019-06-25
Active, closed
AstraZeneca
Phase 3
1,063
Daegu, Goyang-si, Gyeonggi-do, Incheon, Seoul
2018-11-16
Active, closed
AstraZeneca
Phase 3
1,246
Goyang-si, Incheon, Seoul, Suwon
2018-09-27
Active, closed
AstraZeneca
Phase 3
216
Cheongju-si, Incheon, Seongnam-si, Seoul
2018-07-19
Active, closed
AstraZeneca
Phase 2
154
Incheon, Seoul
2018-03-16
Active, closed
AstraZeneca
Phase 2
273
Cheongju-si, Daegu, Goyang-si, Incheon, Seongnam-si, Seoul
2018-03-07
Active, closed
Savolitinib vs. Sunitinib in MET-driven PRCC.
NCT03091192Carcinoma, Carcinoma, Renal Cell, Kidney Neoplasms, Urologic Neoplasms
DrugsSavolitinib·Sunitinib
AstraZeneca
Phase 3
60
Daejeon, Goyang-si, Hwasun-gun, Incheon, Seoul
2017-07-25
Active, closed
AstraZeneca
Phase 3
1,186
Busan, Chungcheongbuk-do, Daegu, Incheon, Seongnam-si, Seoul, Ulsan
2017-06-01
Active, closed
AstraZeneca
Phase 3
987
Changwon, Cheongju-si, Daegu, Incheon, Jinju, Seongnam-si, Seoul
2017-03-27
Active, closed
AstraZeneca
Phase 3
669
Changwon-si, Cheongju-si, Daegu, Incheon, Jinju, Seoul, Suwon
2017-01-02
Active, closed
AstraZeneca
Phase 3
1,126
Incheon, Seongnam-si, Seoul
2015-11-02
Active, closed
AstraZeneca
Phase 3
1,118
Busan, Changwon-si, Cheongju-si, Daegu, Daejeon, Goyang-si, Incheon, Jinju
2015-07-21
Active, closed
AstraZeneca
Phase 3
1,837
Daegu, Goyang-si, Incheon, Seongnam-si, Seoul
2014-04-22
Rows per page Showing 1–36 of 36
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a South Korean investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 11 October 2026. https://priyalifescience.com/clinical-trials-south-korea/city/incheon

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in South Korea and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 3,365 studies in total at the last sync on 11 Oct 2026, 03:17 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 36 of those studies with a site in Incheon that also match the filters currently applied.

How many clinical trials are recruiting in Incheon?

14 of the 36 studies on this page are recruiting new participants as of the 11 Oct 2026, 03:17 UTC sync. A further 0 have not yet opened recruitment, 22 are active but closed to new participants, and 0 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Incheon), 36 studies
PhaseStudiesRecruitingShare
Phase 3281077.8%
Phase 26216.7%
Observational225.6%

Most active sponsors

Lead sponsors with the most studies (Incheon)
Lead sponsorStudiesRecruiting
AstraZeneca3614
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.